Photo: Courtesy of Celgene ( Celgene Logo, https://www.celgene.com/media-library/celgene-logo/)

29 September 2015Americas

Celgene reiterates stance on Kyle Bass IPRs

Biopharmaceutical company Celgene has reiterated its stance on the inter partes review (IPR) petitions filed by hedge fund manager Kyle Bass and has hinted it will appeal against a recent unfavourable decision.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk